Delivery Order SPE2DB24D1205-SPE2DB25FCTWP
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,914.22, is for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The award is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,723.87 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,927.98, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency. The $1,152.16 Firm Fixed Price Delivery Order contract is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract has an ultimate completion date of February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,791.65 contract is for the delivery of 1,000 units of Tamsulosin HCl 0.4 mg capsules, a medication used to treat an enlarged prostate. The order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,074.38 firm-fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of September 9, 2024 and was awarded on September 6, 2024. Amerisourcebergen holds several Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.76 firm-fixed-price contract is for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat an enlarged prostate. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,385.29 delivery order contract is for the supply of 4,563,500 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate gland. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. The contract is a firm fixed price type with no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,168.74 firm-fixed-price contract is for the delivery of 1,000 capsules of Tamsulosin Hydrochloride 0.4 milligram, a medication used to treat the symptoms of an enlarged prostate. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,315.27, is for the delivery of 500 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...